Current use of selective serotonin reuptake inhibitors was associated with a 23.3% risk of 30-day stroke mortality among diabetes patients hospitalized for stroke, compared with a 15.8% risk among those who didn't take the drugs.
Read More »CGM Motivates Prediabetes and Type 2 Patients to Increase Physical Activity
Using a continuous glucose monitor helps those with prediabetes and type 2 diabetes to self-regulate their exercise.
Read More »Can a Low-Calorie Diet Reverse Diabetes?
In study, 40 percent of adults with type 2 diabetes achieved a fasting glucose level of less than 126mg/dL.(7mmol/L) after eight weeks on a very low-calorie diet.
Read More »Standing or Sitting?
To combat the negative effects of too much sitting, standing desks have been rising in popularity. But does the science support their supposed benefits?
Read More »Acupuncture Helps to Increase Insulin Sensitivity
Electro-acupuncture may be beneficial through different mechanisms: weight loss, anti-inflammatory effects, and improvement of lipid metabolism and adipokines.
Read More »Do Lifestyle Interventions Fix Diabetes Depression?
Meta-analysis examines the effectiveness of interventions in improving and preventing diabetes depression.
Read More »No Higher Risk of Heart Failure with DPP-4 Inhibitors
Type 2 patients who used saxagliptin or sitagliptin had similar risks for heart failure as those who received other anti-hyperglycemic agents, according to a retrospective cohort study.
Read More »The Safest First-Line Therapy for Type 2 Diabetes
According to more than 200 studies involving 1.4 million patients, metformin reduces heart disease risk in diabetes patients more effectively than its competitors.
Read More »New GLP-1 Drug Shows Cardiovascular Benefit
This is the fourth drug to treat diabetes that also can reduce the risk of heart disease.
Read More »Januvia for High Risk CVD Patients is Safe
A secondary analysis of the TECOS trial affirms sitagliptin does not increase heart failure risk for patients with type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.